Medbroker ApS: Financial statements 2025
CVR: 31892236
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Medbroker ApS (CVR 31892236) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -6,226 and a net result of DKK -78,938 compared with DKK -406,760 the year before. Equity in the 2025 report amounted to DKK 34,714. The solvency ratio was 10.6%.
- Gross Profit
- DKK -6,226
- Profit/Loss
- DKK -78,938
- Equity
- DKK 34,714
- Total Assets
- DKK 328,870
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -6 t. | -79 t. | 35 t. | 0 |
| 2024 | - | -144 t. | -407 t. | 114 t. | 0 |
| 2023 | - | -66 t. | -405 t. | 520 t. | 1 |
| 2022 | - | -57 t. | -335 t. | 925 t. | 1 |
| 2021 | - | 130 t. | -343 t. | 1.3 mio. | 1 |
Official annual report
How creditworthy is Medbroker ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Medbroker ApS has published its annual report for 2024. Gross profit came to DKK -144,251, and the net result was DKK -406,760.
About Medbroker ApS
Medbroker ApS is a Danish company of the type Anpartsselskab based in Gadstrup, founded in 2009. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ORIGO BIOTECH ApS. The management consists of Henrik Carlheim Dørge. The board consists of Henrik Carlheim Dørge (chair). The company is owned by MEDBROKER INVEST ApS. The company has 3 employees (2023). In 2025, the company reported a gross profit of DKK -6,226 and a net result of DKK -78,938 compared with DKK -406,760 the year before. Equity in the 2025 report amounted to DKK 34,714.